JERUSALEM, March 21, 2022 /PRNewswire/ — Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the progressive alpha-radiation most cancers remedy Alpha DaRT™, at present introduced the appointment of Ms. Ruth (Ruti) Alon to its Board of Administrators, efficient instantly.
“We’re happy to welcome Ruti as the most recent member of our Board of Administrators,” mentioned Uzi Sofer, Chief Government Officer and Chairman of Alpha Tau. “Ruti’s intensive information and expertise advising healthcare firms via monetary and strategic operations shall be an incredible asset to the Firm. We’re desirous to have her on board and profit from her insights into our company and medical plan as we develop the Firm.”
Ruti Alon added, “I’ve been following Alpha Tau from its inception, at all times believing within the know-how and its potential. I’m very excited to affix the Firm and its Board at this crucial juncture, and I look ahead to being a part of bringing a extra superior know-how to sufferers all over the world affected by a wide range of strong tumors.”
About Ruti Alon
Ms. Alon is presently the founder and CEO of Medstrada. From 1997 and till December 24, 2016, Ms. Alon served as a normal companion in Pitango Enterprise Capital. Previous to her tenure at Pitango, Ms. Alon held senior positions with Montgomery Securities from 1981 to 1987, Genesis Securities, LLC from 1993 to 1996, and Kidder Peabody & Co. from 1987 to 1993, and managed her personal unbiased consulting enterprise in San Francisco within the medical units trade from 1995 to 1996. Ms. Alon was the founder and Chairperson of Israel Life Science Business, a not-for-profit group representing the mutual targets of the then roughly 1,000 Israeli life science firms. She was additionally the co-founder of the Israeli Superior Expertise Industries (IATI), an umbrella group of the hi-tech and life sciences industries in Israel, which incorporates enterprise capital funds, R&D facilities of multinational firms and others. She presently serves on the boards of Vascular Biogenics Ltd (Nasdaq:VBLT), Moringa Acquisition Corp (NASDAQ:MACA), Treos Bio (privately held), Phoska BioPharma (privately held), Blue Tree Applied sciences (privately held), and Brainsgate (privately held) (as Chairperson). Ms. Alon has a B.A. in Economics from the Hebrew College of Jerusalem, Israel, an M.B.A. from Boston College, and an M.S. from the Columbia College College of Physicians and Surgeons.
About Alpha DaRT
Alpha DaRT (Diffusing Alpha-emitters Radiation Remedy) is designed to allow extremely potent and conformal alpha-irradiation of strong tumors by intratumoral supply of radium-224 impregnated sources. When the radium decays, its short-lived daughters are launched from the supply and disperse whereas emitting high-energy alpha particles with the objective of destroying the tumor. For the reason that alpha-emitting atoms diffuse solely a brief distance, Alpha DaRT goals to primarily have an effect on the tumor, and to spare the wholesome tissue round it.
About Alpha Tau Medical Ltd.
Based in 2016, Alpha Tau is an Israeli medical gadget firm that focuses on analysis, growth, and potential commercialization of the Alpha DaRT for the remedy of strong tumors. The know-how was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv College.
Investor Relations Contact:
SOURCE Alpha Tau Medical